BusinessAdaptimmune Announces Two Manufacturing Achievements on Its way to Become the First Fully Integrated TCR T-cell Therapy CompanyBy Nasdaq OMXJan 8, 2018, 1:00 PM UTC
BusinessAdaptimmune Announces Positive Safety Data from Pilot Studies with MAGE-A10 SPEAR T-cells and First Patient to Receive 1 billion Target Cell DoseBy Nasdaq OMXJan 8, 2018, 1:00 PM UTC
BusinessTeneobio Announces a Strategic Alliance with TESARO to Develop the Next Generation of Immuno-Oncology, Multispecific AntibodiesBy Nasdaq OMXJan 8, 2018, 1:00 PM UTC
BusinessPaul Stead Joins Adaptimmune as Vice President of Business DevelopmentBy Nasdaq OMXJan 4, 2018, 1:02 PM UTC
BusinessGeoVax and Vaxeal to Collaborate on Cancer Immunotherapy ProgramBy Nasdaq OMXJan 3, 2018, 2:00 PM UTC
BusinessaTyr Pharma Announces Poster Presentation at ASCO-SITC Clinical Immuno-Oncology SymposiumBy Nasdaq OMXDec 21, 2017, 1:01 PM UTC
BusinessCrown Bioscience Releases Scientific Posters Detailing Innovations in Preclinical Cancer PharmacologyBy Nasdaq OMXDec 7, 2017, 3:36 PM UTC
BusinessMolecularMD to Implement Promega’s Microsatellite Instability (MSI) Technology for Immuno-Oncology ApplicationsBy Nasdaq OMXNov 14, 2017, 1:00 AM UTC
